Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Q32 Bio Announced That It Has Dosed The First Patients In Both The Part A Open-label Extension (OLE) And Part B Of The Signal-aa Phase 2A Clinical Trial Evaluating Bempikibart In Patients With Alopecia Areata (AA)

Author: Benzinga Newsdesk | April 16, 2025 07:00am

Posted In: QTTB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist